Sec. 562.153. REQUIREMENTS FOR OFFICE USE COMPOUNDING

Latest version.

To dispense and deliver a compounded drug under Section 562.152, a pharmacy must:
(1) verify the source of the raw materials to be used in a compounded drug;
(2) comply with applicable United States Pharmacopoeia guidelines, including the testing requirements, and the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191);
(3) comply with all applicable competency and accrediting standards as determined by the board; and
(4) comply with board rules, including rules regarding the reporting of adverse events by practitioners and recall procedures for compounded products.

Amended by: Acts 2005, 79th Leg., Ch. 28 , Sec. 4, eff. September 1, 2005.

                    
                        var val = document.getElementById('citecontent').innerHTML;
                        art.dialog.defaults.title = window.location.href;
                        art.dialog.data('cite', val);
                        art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                        art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');